The emergence of potent and selective peptide leukotriene receptor antagonists
- 31 December 1989
- journal article
- review article
- Published by Elsevier in Pulmonary Pharmacology
- Vol. 2 (1) , 27-31
- https://doi.org/10.1016/s0952-0600(89)80006-7
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Wy-48,252 (1,1,1-trifluoro-N-[3-(2-quinolinylmethoxy)phenyl]methane sulfonamide), an orally active leukotriene antagonist: effects on arachidonic acid metabolism in various inflammatory cellsEuropean Journal of Pharmacology, 1988
- Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and InflammationScience, 1983
- Local Effects of Synthetic Leukotrienes (LTC4, LTD4, and LTB4) in Human SkinJournal of Investigative Dermatology, 1983
- Leukotriene-C4 enhances mucus production from submucosal glands in canine trachea in vivoInternational Journal of Immunopharmacology, 1983
- Evidence for multiple leukotriene D4 receptors in smooth muscleLife Sciences, 1982
- Pharmacological study of the contractile activity of leukotriene C4 and D4 on isolated human airway smooth muscleCanadian Journal of Physiology and Pharmacology, 1982
- Leukotriene B4 — a stereospecific stimulator for release of lysosomal enzymes from neutrophilsFEBS Letters, 1981
- Slow-reacting substances (leukotrienes) contract human airway and pulmonary vascular smooth muscle in vitroNature, 1981
- Total synthesis of slow reacting substances (SRS). “Leukotriene C-2” (11-Tetrahedron Letters, 1980
- Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature, 1980